fenofibrate
The following drugs will decrease fenofibrate effect
the follwing drugs will
Increase fenofibrate effect
The follwing drugs will Increase effect by fenofibrate effect
| # | enzyme | drug | level |
| 1 | 2C9 | amitriptyline | In-Vitro Only |
| 2 | 2C9 | azilsartan | In-Vitro Only |
| 3 | 2C9 | capecitabine | In-Vitro Only |
| 4 | 2C9 | celecoxib | In-Vitro Only |
| 5 | 2C9 | clopidogrel | In-Vitro Only |
| 6 | 2C9 | diclofenac | In-Vitro Only |
| 7 | 2C9 | doxepin | In-Vitro Only |
| 8 | 2C9 | fluoxetine | In-Vitro Only |
| 9 | 2C9 | fluvastatin | In-Vitro Only |
| 10 | 2C9 | glibenclamide | In-Vitro Only |
| 11 | 2C9 | glimepiride | In-Vitro Only |
| 12 | 2C9 | glipizide | In-Vitro Only |
| 13 | 2C9 | glyburide | In-Vitro Only |
| 14 | 2C9 | ibuprofen | In-Vitro Only |
| 15 | 2C9 | irbesartan | In-Vitro Only |
| 16 | 2C9 | lesinurad | In-Vitro Only |
| 17 | 2C9 | lornoxicam | In-Vitro Only |
| 18 | 2C9 | losartan | In-Vitro Only |
| 19 | 2C9 | meloxicam | In-Vitro Only |
| 20 | 2C9 | nateglinide | In-Vitro Only |
| 21 | 2C9 | olodaterol | In-Vitro Only |
| 22 | 2C9 | ospemifene | In-Vitro Only |
| 23 | 2C9 | phenytoin | In-Vitro Only |
| 24 | 2C9 | piroxicam | In-Vitro Only |
| 25 | 2C9 | rosiglitazone | In-Vitro Only |
| 26 | 2C9 | s-warfarin | In-Vitro Only |
| 27 | 2C9 | suprofen | In-Vitro Only |
| 28 | 2C9 | tamoxifen | In-Vitro Only |
| 29 | 2C9 | tolbutamide | In-Vitro Only |
| 30 | 2C9 | torsemide | In-Vitro Only |
| 31 | 2C9 | valproic acid | In-Vitro Only |
| 32 | 2C9 | venlafaxine | In-Vitro Only |
| 33 | 2C9 | voriconazole | In-Vitro Only |
| 34 | 2C9 | zafirlukast | In-Vitro Only |
will
decrease fenofibrate effect
fenofibrate will not affect
Strong inhibitor is one that causes a ≥ 5-fold decrease in the plasma AUC values or more than 80% decrease in clearance.
Moderate inhibitor is one that causes a 2 fold to < 5-fold decrease in the plasma AUC values or 50-80% decrease in clearance.
Weak inhibitor is one that causes a ≥ 1.25-fold but < 2-fold decrease in the plasma AUC values or 20-50% decrease in clearance.
In-Vitro Only In-Vitro Only Inhibitor strength.
under review Inhibitor strength level is under review.